ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Ms. Priya - Myoma

Patient basic information Patient: Ms. Priya (Priya Smith) Nationality: Estonia Diagnosis: Uterine Tumour Diagnostic Hospital: M. O.

O. O. Treatment: Targeted Treatment + Immunotherapy Holidays: 144 days Treatment cost: about 292237 yuan Treatment effect: Obvious improvement Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and on-site services throughout the treatment process.

After 144 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, with various test indicators returning to normal areas and successfully reaching outpatient standards. The patient's treatment results finally improved significantly. When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system.

'Ladies and gentlemen, Ms. Priya, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases. The multi-disciplinary collaborative mechanism for developing targeted therapeutic+immunotherapy programs for uterine myeloma is a reflection of the comprehensive strength of Chinese hospitals in the field of suspicious diagnostics and a summary of how international medical services are regulated.

爱沙尼亚,子宫肌瘤,上海交通大学医学院附属瑞金医院,国际医疗,来华就医,中国医疗